Precursor frequency can compensate for lower TCR expression in T cell competition during priming in vivo

European Journal of Immunology

Volumn 36, Issue 10, 2006, Pages 2613-2623

  Rechtsteiner, Gerd ^a   Warger, Tobias ^a   Hofmann, Matthias ^b   Rammensee, Hans Georg ^c   Schild, Hans Jörg ^a   Radsak, Markus P ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b NOVARTIS PHARMA AG   (Switzerland)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Avidity; Cytotoxic T cells; Immunodominance; Precursor frequency

Indexed keywords

CD2 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; CD5 ANTIGEN; CD8 ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; CD8+ T LYMPHOCYTE; CELL CLONING; CELL INTERACTION; CELL SPECIFICITY; CELLULAR IMMUNITY; CLONAL VARIATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; RECEPTOR DENSITY; STEM CELL; TRANSGENIC MOUSE;

ADOPTIVE TRANSFER; ANIMALS; ANTIGEN PRESENTATION; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; STEM CELLS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 33750225639     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200636331     Document Type: Article

References (45)

1. Zinkernagel, R. M. and Doherty, P.C., MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. Adv. Immunol. 1979. 27: 51-177.
2. Zeh, H. J. III, Perry-Lalley, D., Dudley, M. E., Rosenberg, S. A. and Yang, J. C., High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy. J. Immunol. 1999. 162: 989-994.
3. Steinman, R. M. and Nussenzweig, M. C., Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. USA 2002. 99: 351-358.
4. Rammensee, H. G., Falk, K. and Rotzschke, O., Peptides naturally presented by MHC class I molecules. Annu. Rev. Immunol. 1993. 11: 213-244.
5. Yewdell, J. W. and Bennink, J. R., Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu. Rev. Immunol. 1999. 17: 51-88.
6. + T cell responses. Proc. Natl. Acad. Sci. USA 2005. 102: 11432-11437.
7. Chen, W., Anton, L. C., Bennink, J. R. and Yewdell, J. W., Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. Immunity 2000. 12: 83-93.
8. Deng, Y., Yewdell, J. W., Eisenlohr, L. C. and Bennink, J. R., MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL. J. Immunol. 1997. 158: 1507-1515.
9. Eisenlohr, L. C., Yewdell, J. W. and Bennink, J. R., Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes. J. Exp. Med. 1992. 175: 481-487.
10. Sette, A., Vitiello, A., Reherman, B., Fowler, P., Nayersina, R., Kast, W. M., Melief, C. J. et al., The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 1994. 153: 5586-5592.
11. + T cell immunodominance hierarchy determined by antigen dose and precursor frequencies. Proc. Natl. Acad. Sci. USA 2006. 103: 994-999.
12. Smith, A. L., Wikstrom, M. E. and Fazekas de St. Groth, B., Visualizing T cell competition for peptide/MHC complexes: a specific mechanism to minimize the effect of precursor frequency. Immunity 2000. 13: 783-794.
13. Kedl, R. M., Rees, W. A., Hildeman, D. A., Schaefer, B., Mitchell, T., Kappler, J. and Marrack, P., T cells compete for access to antigen-bearing antigen-presenting cells. J. Exp. Med. 2000. 192: 1105-1113.
14. Probst, H. C., Tschannen, K., Gallimore, A., Martinic, M., Basler, M., Dumrese, T., Jones, E. and van den Broek, M. F., Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression. J. Immunol. 2003. 171: 5415-5422.
15. Grufman, P., Sandberg, J. K, Wolpert, E. Z. and Karre, K., Immunization with dendritic cells breaks immunodominance in CTL responses against minor histocompatibility and synthetic peptide antigens. J. Leukoc. Biol. 1999. 66: 268-271.
16. Grufman, P., Wolpert, E. Z., Sandberg, J. K. and Karre, K., T cell competition for the antigen-presenting cell as a model for immunodominance in the cytotoxic T lymphocyte response against minor histocompatibility antigens. Eur. J. Immunol. 1999. 29: 2197-2204.
17. Wolpert, E. Z., Grufman, P., Sandberg, J. K., Tegnesjo, A. and Karre, K., Immunodominance in the CTL response against minor histocompatibility antigens: interference between responding T cells, rather than with presentation of epitopes. J. Immunol. 1998. 161: 4499-4505.
18. Berzofsky, J. A., Ahlers, J. D. and Belyakov, I. M., Strategies for designing and optimizing new generation vaccines. Nat. Rev. Immunol. 2001. 1: 209-219.
19. Busch, D. H. and Pamer, E. G., T cell affinity maturation by selective expansion during infection. J. Exp. Med. 1999. 189: 701-710.
20. Savage, P. A., Boniface, J. J. and Davis, M. M., A kinetic basis for T cell receptor repertoire selection during an immune response. Immunity 1999. 10: 485-492.
21. Rees, W., Bender, J., Teague, T. K., Kedl, R. M., Crawford, F., Marrack, P. and Kappler, J., An inverse relationship between T cell receptor affinity and antigen dose during CD4(+) T cell responses in vivo and in vitro. Proc. Natl. Acad. Sci. USA 1999. 96: 9781-9786.
22. + T cell populations specific for persistent DNA viruses. J. Exp. Med. 2005. 202: 1349-1361.
23. Snyder, J. T., Alexander-Miller, M. A., Berzofskyl, J. A. and Belyakov, I. M., Molecular mechanisms and biological significance of CTL avidity. Curr. HIV Res. 2003. 1: 287-294.
24. Kedl, R. M., Schaefer, B. C., Kappler, J. W. and Marrack, P., T cells down-modulate peptide-MHC complexes on APCs in vivo. Nat. Immunol. 2002. 3: 27-32.
25. Labrecque, N., Whitfield, L. S., Obst, R., Waltzinger, C., Benoist, C. and Mathis, D., How much TCR does a T cell need? Immunity 2001. 15: 71-82.
26. Toes, R. E., Offringa, R., Blom, R. J., Melief, C. J. and Kast, W. M., Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction. Proc. Natl. Acad. Sci. USA 1996. 93: 7855-7860.
27. Hofmann, M., Radsak, M., Rechtsteiner, G., Wiemann, K., Gunder, M., Bien-Grater, U., Offringa, R. et al., T cell avidity determines the level of CTL activation. Eur. J. Immunol. 2004. 34: 1798-1806.
28. Kedl, R. M., Kappler, J. W. and Marrack, P., Epitope dominance, competition and T cell affinity maturation. Curr. Opin. Immunol. 2003. 15: 120-127.
29. + T cell responses: correlation of cytokine profile and TCR avidity. J. Immunol. 2004. 172: 5553-5560.
30. Valitutti, S., Muller, S., Cella, M., Padovan, E. and Lanzavecchia, A., Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 1995. 375: 148-151.
31. + T cells in transgenic mice expressing a class II MHC-restricted antigen receptor. Nature 1989. 341: 746-749.
32. Malherbe, L., Hausl, C., Teyton, L. and McHeyzer-Williams, M. G., Clonal selection of helper T cells is determined by an affinity threshold with no further skewing of TCR binding properties. Immunity 2004. 21: 669-679.
33. Valitutti, S., Muller, S., Dessing, M. and Lanzavecchia, A., Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J. Exp. Med. 1996. 183: 1917-1921.
34. Sloan-Lancaster, J. and Allen, P. M., Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu. Rev. Immunol. 1996. 14: 1-27.
35. + cytolytic T lymphocytes in vivo. Blood 2004. 103: 177-184.
36. Serghides, L., Bukczynski, J., Wen, T., Wang, C., Routy, J. P., Boulassel, M. R., Sekaly, R. P. et al., Evaluation of OX40 ligand as a costimulator of human antiviral memory CD8 T cell responses: comparison with B7.1 and 4-1BBL. J. Immunol. 2005. 175: 6368-6377.
37. + CTL after reinfection. J. Immunol. 2005. 174: 3590-3597.
38. Cayeux, S., Richter, G., Noffz, G., Dorken, B. and Blankenstein, T., influence of gene-modified (IL-7, IL-4, and B7) tumor cell vaccines on tumor antigen presentation. J. Immunol. 1997. 158: 2834-2841.
39. + T cell repertoire against Her-2/neu antigens in neu transgenic mice is of low avidity with antitumor activity. Eur. J. Immunol. 2004. 34: 752-761.
40. Lotz, C., Ferreira, E. A., Drexler, L, Mutallib, S. A., Huber, C., Sutter, G. and Theobald, M., Partial tyrosinase-specific self tolerance by HLA-A*0201-restricted cytotoxic T lymphocytes in mice and man. Int. J. Cancer 2004. 108: 571-579.
41. + T cells: optimal soldiers in the war against viruses and tumors. Immunol. Res. 2005. 31: 13-24.
42. Gross, D. A., Graff-Dubois, S., Opolon, P., Comet, S., Alves, P., Bermaceur-Griscelli, A., Faure, O. et al., High vaccination efficiency of low-affinity epitopes in antitumor immunotherapy. J. Clin. Invest 2004. 113: 425-433.
43. Rechtsteiner, G., Warger, T., Osterloh, P., Schild, H. and Radsak, M. P., Cutting Edge: Priming of CTL by transcutaneous peptide immunization with imiquimod. J. Immunol. 2005. 174: 2476-2480.
44. Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S. and Steinman, R. M., Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 1992. 176: 1693-1702.
45. Warger, T., Osterloh, P., Rechtsteiner, G., Fassbender, M., Heib, V., Schmid, B., Schmitt, E. et al., Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo. Blood 2006. 108: 544-550.